Vein Therapy News Vein Therapy News
  • Home
  • Physicians
  • Digital Issue
    • Latest Issue
    • Back Issues
  • Events
  • Industry News
  • Advertise
  • Subscribe
  • Advisory Board
  • Contact
  • Home
  • Physicians
  • Digital Issue
    • Latest Issue
    • Back Issues
  • Events
  • Industry News
  • Advertise
  • Subscribe
  • Advisory Board
  • Contact
  • 10 Feb 2023 Has your practice seen an increase in blood clots since the COVID vaccines became available?
  • 10 Feb 2023 Janssen’s Xarelto studied for secondary prevention of VTE in cancer patients
  • 10 Feb 2023 Stryker’s Target Tetra detachable coil for treating small aneurysms cleared by FDA
  • 10 Feb 2023 Corindus rebranded as Siemens Healthineers Endovascular Robotics
  • 12 Dec 2022 Cook Medical Appoints John A. Kaufman as Chief Medical Officer
  • 12 Dec 2022 Merit Medical’s EmboCube Embolization Gelatin to Be Studied to Control Bleeding or Hemorrhage
  • 12 Dec 2022 Vesalio’s NeVa Thrombectomy Device First-Pass Rates Evaluated in Published Study
  • 11 Aug 2022 Starting a vein practice? Start here!

Post Box with 3-Cols Boxed Grid Layout

Has your practice seen an increase in blood clots since the COVID vaccines became available?

February 10, 2023
0

Janssen’s Xarelto studied for secondary prevention of VTE in cancer patients

February 10, 2023
0

Stryker’s Target Tetra detachable coil for treating small aneurysms cleared by FDA

February 10, 2023
0

Post Box with Ajax Pagination

Has your practice seen an increase in blood clots since the COVID vaccines became available?

February 10, 2023
0

Janssen’s Xarelto studied for secondary prevention of VTE in cancer patients

February 10, 2023
0

Stryker’s Target Tetra detachable coil for treating small aneurysms cleared by FDA

February 10, 2023
0
Page :
1 2 3 4 … 101

Post Box with 3-Cols Block Grid Layout

10 Feb 2023

Has your practice seen an increase in blood clots since the COVID vaccines became available?

We would like to hear from you! Please call Gary Pittman Jr at 512-637-0373 or email garypjr@pcinews.com.

Vein Therapy News 0
10 Feb 2023

Janssen’s Xarelto studied for secondary prevention of VTE in cancer patients

The Janssen Pharmaceutical Companies of Johnson & Johnson recently announced observational data from 8 years of clinical practice showing that the company’s oral Factor Xa inhibitor Xarelto (rivaroxaban) is associated with comparable effectiveness and safety to the Factor Xa inhibitor apixaban for the treatment of cancer-associated thromboembolism (CAT) in a

Vein Therapy News 0
10 Feb 2023

Stryker’s Target Tetra detachable coil for treating small aneurysms cleared by FDA

Stryker announced FDA 510(k) clearance of the Target Tetra detachable coil, the latest addition to the company’s Target platform. The Target Tetra device, which is specifically designed to treat small aneurysms, combines a new tetrahedral shape and softness level. According to the company, the delicate nature of small aneurysms makes

Vein Therapy News 0

Post Box with 2-Cols Boxed Grid Layout and Sidebar

10 Feb 2023

Has your practice seen an increase in blood clots since the COVID vaccines became available?

We would like to hear from you! Please call Gary Pittman Jr at 512-637-0373 or email garypjr@pcinews.com.

Vein Therapy News 0
10 Feb 2023

Janssen’s Xarelto studied for secondary prevention of VTE in cancer patients

The Janssen Pharmaceutical Companies of Johnson & Johnson recently announced observational data from 8 years of clinical practice showing that the company’s oral Factor Xa inhibitor Xarelto (rivaroxaban) is associated with comparable effectiveness and safety to the Factor Xa inhibitor apixaban for the treatment of cancer-associated thromboembolism (CAT) in a

Vein Therapy News 0

Post Box with 3-Cols Masonry Layout

10 Feb 2023

Has your practice seen an increase in blood clots since the COVID vaccines became available?

We would like to hear from you! Please call Gary Pittman Jr at 512-637-0373 or email garypjr@pcinews.com.

Vein Therapy News 0
10 Feb 2023

Janssen’s Xarelto studied for secondary prevention of VTE in cancer patients

The Janssen Pharmaceutical Companies of Johnson & Johnson recently announced observational data from 8 years of clinical practice showing that the company’s oral Factor Xa inhibitor Xarelto (rivaroxaban) is associated with comparable effectiveness and safety to the Factor Xa inhibitor apixaban for the treatment of cancer-associated thromboembolism (CAT) in a

Vein Therapy News 0
10 Feb 2023

Stryker’s Target Tetra detachable coil for treating small aneurysms cleared by FDA

Stryker announced FDA 510(k) clearance of the Target Tetra detachable coil, the latest addition to the company’s Target platform. The Target Tetra device, which is specifically designed to treat small aneurysms, combines a new tetrahedral shape and softness level. According to the company, the delicate nature of small aneurysms makes

Vein Therapy News 0
Siemens Healthineers
10 Feb 2023

Corindus rebranded as Siemens Healthineers Endovascular Robotics

Corindus, a Siemens Healthineers Company, announced it has been rebranded to Siemens Healthineers Endovascular Robotics, a dedicated business within the Advanced Therapies area of Siemens Healthineers. The aim of the Endovascular Robotics business is to advance interventions with robotics and change the way that care is delivered through innovations that

Vein Therapy News 0
Dr. John A. Kaufman
12 Dec 2022

Cook Medical Appoints John A. Kaufman as Chief Medical Officer

Cook Medical announced the appointment of John A. Kaufman, MD, MS, as Chief Medical Officer (CMO), effective July 2023. Currently, Dr. Kaufman is the inaugural Chair of the Dotter Department of Interventional Radiology, Director of the Dotter Interventional Institute, and Frederick S. Keller Professor of Interventional Radiology at the Oregon

Vein Therapy News 0
Embocubes
12 Dec 2022

Merit Medical’s EmboCube Embolization Gelatin to Be Studied to Control Bleeding or Hemorrhage

Merit Medical Systems, Inc. announced the enrollment of the first patient in the company’s prospective, observational study of EmboCube embolization gelatin to control bleeding or hemorrhage. The EmboCube Embolization Gelatin study is designed to enroll 100 patients across multiple centers in Australia and France. The company advised that EmboCube is

Vein Therapy News 0
  • News

    Has your practice seen an increase in blood clots since the COVID vaccines became available?

    Vein Therapy News — February 10, 2023
  • Siemens Healthineers
    News

    Corindus rebranded as Siemens Healthineers Endovascular Robotics

    Vein Therapy News — February 10, 2023
  • Dr. John A. Kaufman
    News

    Cook Medical Appoints John A. Kaufman as Chief Medical Officer

    Vein Therapy News — December 12, 2022

Post Carousel

  • News

    Has your practice seen an increase in blood clots since the COVID vaccines became available?

  • News

    Janssen’s Xarelto studied for secondary prevention of VTE in cancer patients

  • News

    Stryker’s Target Tetra detachable coil for treating small aneurysms cleared by FDA

  • Siemens Healthineers
    News

    Corindus rebranded as Siemens Healthineers Endovascular Robotics

  • Dr. John A. Kaufman
    News

    Cook Medical Appoints John A. Kaufman as Chief Medical Officer

Post Box with Classic Layout and Sidebar

10 Feb 2023

Has your practice seen an increase in blood clots since the COVID vaccines became available?

We would like to hear from you! Please call Gary Pittman Jr at 512-637-0373 or email garypjr@pcinews.com.

Vein Therapy News 0 Read More
10 Feb 2023

Janssen’s Xarelto studied for secondary prevention of VTE in cancer patients

The Janssen Pharmaceutical Companies of Johnson & Johnson recently announced observational data from 8 years of clinical practice showing that the company’s oral Factor Xa inhibitor Xarelto (rivaroxaban) is associated with comparable effectiveness and safety to the Factor Xa inhibitor apixaban for the treatment of cancer-associated thromboembolism (CAT) in a

Vein Therapy News 0 Read More
10 Feb 2023

Stryker’s Target Tetra detachable coil for treating small aneurysms cleared by FDA

Stryker announced FDA 510(k) clearance of the Target Tetra detachable coil, the latest addition to the company’s Target platform. The Target Tetra device, which is specifically designed to treat small aneurysms, combines a new tetrahedral shape and softness level. According to the company, the delicate nature of small aneurysms makes

Vein Therapy News 0 Read More

Latest Posts

News

Has your practice seen an increase in blood clots since the COVID vaccines became available?

News

Janssen’s Xarelto studied for secondary prevention of VTE in cancer patients

News

Stryker’s Target Tetra detachable coil for treating small aneurysms cleared by FDA

Recent Posts

  • Has your practice seen an increase in blood clots since the COVID vaccines became available?
  • Janssen’s Xarelto studied for secondary prevention of VTE in cancer patients
  • Stryker’s Target Tetra detachable coil for treating small aneurysms cleared by FDA
  • Corindus rebranded as Siemens Healthineers Endovascular Robotics
  • Cook Medical Appoints John A. Kaufman as Chief Medical Officer

Categories

  • Business News
  • Case Studies
  • Education
  • Events
  • Government
  • LYMPHEDEMA
  • News
  • Payers
  • Physicians
  • Product News
  • Researchers
  • SecondLook
  • Subscription
  • The Practice
  • VTN Advisory Board

Custom Content Section

You can place any content here, including Advertising. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Quisque scelerisque lectus nec est feugiat, at eleifend sapien suscipit. Cras in neque ac nulla blandit auctor sed ut purus. Curabitur metus elit, tristique id auctor a, fermentum imperdiet felis. Maecenas imperdiet facilisis nibh at viverra. Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Cras euismod rhoncus nibh, et vestibulum justo bibendum et. Quisque sed vehicula erat. Nulla cursus a nisi a tincidunt. Curabitur pulvinar, urna quis volutpat dignissim, libero est fermentum mauris, ut rutrum metus lacus at ipsum. Donec rhoncus leo eget dolor gravida ullamcorper. Suspendisse tempus, velit condimentum hendrerit ultrices, tellus libero auctor leo, non feugiat libero dui a tellus.

  • Home
  • Physicians
  • Events
  • Latest Issue
  • Industry News
  • Subscribe
  • Advisory Board
  • Advertise
  • Contact
  • Privacy Policy
  • PHYSICIAN-COMPOUNDED FOAM
Copyright ©, 2020 Vein Therapy News. Publications & Communications, LP. All Rights Reserved. Designated trademarks and brands are the property of their respective owners.


SHARE

Page Composer – All Blocks